Laurus Labs Limited
LAURUSLABSNSE•Healthcare
Previous Close
₹944.90
Last Updated
20 Mar, 07:18 am
Market Cap
N/A
P/E Ratio
62.963436
52W High
₹1,141.00
52W Low
₹517.65
Open
₹975.00
High
₹975.20
Low
₹936.30
Volume
8,28,211
Price Chart with Technical Indicators
• Blue line: Stock price
• Yellow dashed line: 20-day moving average
• Red dashed line: 50-day moving average
• Gray line: Trading volume (scaled for visualization)
Performance Analysis
52W Range Position
74.4%
Above midpoint
From 52W High
14.0%
From 52W Low
+89.6%
Average Price
₹944.90
Trading Metrics
Volume
8,28,211
Avg Volume
13,29,260
Volume Ratio
0.62x
Normal
Volatility
N/A
Moderate
Financial Fundamentals
Profit
₹0.00 Cr
Debt
₹0.00 Cr
Risk Assessment
Price Stability
Volatile
Market Position
Strong
Liquidity
Moderate
Valuation Metrics
P/E Ratio
62.963436
Overvalued
About Laurus Labs Limited
Laurus Labs Limited, together with its subsidiaries, manufactures and sells medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company offers Generics APIs and oral solid formulations for advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, anti-asthma, ophthalmology, oncology, gastroenterology, and hepatitis C therapeutic areas. It also provides biotechnology services used in the nutraceutical, dietary supplements, alternate food proteins, and cosmeceutical products. In addition, the company develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceuticals field. Laurus Labs Limited was incorporated in 2005 and is based in Hyderabad, India.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Latest News
No news available for this stock.